ULP announces Lionheart Health as the winner of the inaugural Golden Passport Pitch Competition, sponsored by Allergan Aesthetics, an AbbVie Company.
Lionheart Health will be awarded a 1-year sponsored lab bench at University Lab Partners, the premier wet lab incubator in Irvine, CA. In addition, Lionheart Health's team will have the opportunity to engage with industry mentors including scientific and business leaders from Allergan Aesthetics and ULP.
"Through our support of Lionheart Health, Allergan Aesthetics is continuing to drive innovation in aesthetics medicine forward and accelerating the growth and development of entrepreneurs and researchers in the field," saidDarin Messina, Ph.D., Senior Vice President, Allergan Aesthetics R&D, AbbVie. "We are committed to continued investment in early science and regenerative technologies and defining the future blueprint for the aesthetics industry."
Howard Leonhardt, Founder and CEO of Lionheart Health shared, "We are grateful for the Golden Passport opportunity offered through Allergan Aesthetics and University Lab Partners. This support is essential to scaling Lionheart Health's aesthetics applications, improving health span, and overall quality of life."
The 2023 winner was chosen among many worthy applicants by an expert panel of judges includingCharlie Hee, Ph.D., Vice President, Device R&D Fillers and Device Sciences, Allergan Aesthetics, Dr.Sherly Soleiman, Founder of Cosmetic Injectables Center, Dr.Arisa E. Ortiz, Director of Laser and Cosmetic Dermatology and Associate Clinical Professor of Dermatology at UC San Diego, Dr.Hisham Seifyfrom Newport Plastic and Reconstructive Surgery Associates and Prestige Surgery Center, andMichael Hill, Managing Director at Octane Capital Markets.
Life science startups at ULP benefit from professional mentoring and consulting with Experts-in-Residence, networking events, and unique access to technical core facilities. Since 2019, ULP has incubated a total 64 companies with over$535Mraised and successfully graduated 8 startups.